SCHEMBL4882804

SCHEMBL4882804

CC(C)(C)[Si](C)(C)Oc1c2c(C(=O)O)c(c(-c3ccccc3)c1-c1ccccc1)OCO2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PREP P48147 3/20 0.50
PRNP P04156 1/20 0.35
PPARG P37231 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
NR2E3 Q9Y5X4 1/20 0.35
NCOR2 Q9Y618 1/20 0.35
LMNA P02545 2/20 0.35
TARBP2 Q15633 2/20 0.33
FABP3 P05413 3/20 0.33
FABP4 P15090 3/20 0.33
TACR1 P25103 1/20 0.32
ALDH1A1 P00352 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
TSHR P16473 1/20 0.32
PDE10A Q9Y233 1/20 0.32
EDNRA P25101 1/20 0.31
FABP5 Q01469 2/20 0.31
KDM4E B2RXH2 2/20 0.31
NPC1 O15118 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7050554 0.74 LMNA (0.44) LMNAALDH1A1SMN1; SMN2TSHRPDE10A
SCHEMBL29034603 0.73 PDE4B (0.40) PREPPRNPPPARGRXFP1NR2E3
SCHEMBL11189652 0.73 PDE10A (0.39) PRNPPPARGRXFP1NR2E3NCOR2
SCHEMBL7050556 0.68 LMNA (0.44) PRNPPPARGRXFP1NR2E3NCOR2
SCHEMBL29034599 0.63 BACE1 (0.43) LMNAALDH1A1SMN1; SMN2PDE10AKDM4E
SCHEMBL2356942 0.62 AKT2 (0.36) PREPLMNAALDH1A1SMN1; SMN2HPGD
SCHEMBL6012205 0.62 PREP (0.38) PREP
SCHEMBL4882805 0.62 P2RX3 (0.35) PREPALDH1A1SMN1; SMN2PDE10AKDM4E
SCHEMBL7825856 0.62 PREP (0.46) PREPTARBP2EDNRANPC1MAPT
SCHEMBL4922175 0.62 ERCC1 (0.43) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080070850-A1 GALLOTANNINS AND ELLIGITANNINS AS REGULATORS OF CYTOKINE RELEASE THE PENN STATE RESEARCH FOUNDATION (US) 2008-03-20 US claimed
EP-1232169-A1 GALLOTANNINS AND ELLAGITANNINS AS REGULATORS OF CYTOKINE RELEASE THE PENN STATE RESEARCH FOUNDATION (US) 2002-08-21 EP claimed
WO-2001036436-A1 GALLOTANNINS AND ELLAGITANNINS AS REGULATORS OF CYTOKINE RELEASE THE PENN STATE RESEARCH FOUNDATION (US) 2001-05-25 WO claimed
US-20080070850-A1 GALLOTANNINS AND ELLIGITANNINS AS REGULATORS OF CYTOKINE RELEASE THE PENN STATE RESEARCH FOUNDATION (US) 2008-03-20 US disclosed
US-7288273-B1 Gallotannins and ellagitannins as regulators of cytokine release THE PENN STATE RESEARCH FOUNDATION (US) 2007-10-30 US disclosed
EP-1232169-A1 GALLOTANNINS AND ELLAGITANNINS AS REGULATORS OF CYTOKINE RELEASE THE PENN STATE RESEARCH FOUNDATION (US) 2002-08-21 EP disclosed
WO-2001036436-A1 GALLOTANNINS AND ELLAGITANNINS AS REGULATORS OF CYTOKINE RELEASE THE PENN STATE RESEARCH FOUNDATION (US) 2001-05-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070850-A1 GALLOTANNINS AND ELLIGITANNINS AS REGULATORS OF CYTOKINE RELEASE IL2, IL6, TNF PREP 692/4885PRNP 4717/4885PPARG 1230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.